特里帕诺索马克鲁兹RNA结合蛋白DRBD3:在暴露于本兹尼达时形成周核焦点
Daniela F Chame1, Daniela DE Laet-Souza1, Helaine G S Vieira2
1Universidade Federal de Minas Gerais, Instituto de Ciências Biológicas, Departamento de Bioquímica e Imunologia, Avenida Antônio Carlos, 6627, 31270-901 Belo Horizonte, MG, Brazil.
Anais da Academia Brasileira de Ciencias
|November 28, 2024
概括
本兹尼达治疗导致Trypanosoma cruzi中的RNA结合蛋白TcDRBD3形成RNA颗粒. 这些含有RNA的颗粒根据细胞压力而改变位置,影响查加斯病治疗.
科学领域:
- 分子生物学分子生物学
- 寄生虫学的寄生虫学
- 药物发现 药物发现
背景情况:
- 查加斯病是一种被忽视的热带疾病,主要用本津 (BZ) 治疗.
- 特里帕诺索马克鲁兹基因表达依赖于转录后调节,涉及RNA结合蛋白和RNA颗粒.
- 本兹尼达的疗效有限,需要对T. cruzi生物学有更深入的了解.
研究的目的:
- 为了描述T. cruzi的RNA结合蛋白DRBD3 (TcDRBD3).
- 研究在本津治疗和其他压力条件下TcDRBD3的局部化和行为.
主要方法:
- 包括其蛋白质域在内的TcDRBD3的特征.
- 使用标记TcDRBD3 (rTcDRBD3) 来通过显微镜追踪其位置.
- 在各种压力条件下 (BZ,菌素,饥饿) 使用rTcDRBD3进行RNA染色和局部化研究.
主要成果:
- TcDRBD3局限于细胞质,但在暴露于本兹尼达时形成周核焦点.
- BZ和普罗米辛治疗诱导TcDRBD3与RNA的同位化,表明这些颗粒含有多体释放RNAs.
- 在饥饿状态下,TcDRBD3颗粒的定位在整个细胞质中发生变化,并且随着胺素的存在而增加.
结论:
- TcDRBD3形成RNA颗粒,在本兹尼达治疗后积聚在周核区域.
- 含有TcDRBD3的RNA颗粒的定位是动态的,并且依赖于压力.
- 了解TcDRBD3在RNA调节中的作用可能为改善查加斯病治疗提供新的途径.
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...